Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-989-5 | CAS number: 2156592-46-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions, read-across
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium, other: Strains TA 1535, TA 1537, TA 1538, TA 100 and TA 98
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix, derived from the livers of male adult rats induced with Aroclor 1254
- Test concentrations with justification for top dose:
- Concentration range in the main test (with metabolic activation): 1, 10, 100, 1000 and 10000 µg/plate
Concentration range in the main test (without metabolic activation): 1, 10, 100, 1000 and 10000 µg/plate - Vehicle / solvent:
- - Solvent: DMSO
- concentration 100 mg test substance/mL
- Justification for choice of solvent/vehicle: no data - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- other: without S9 mix: 9-Aminoacridine (40 µg/plate) with strain TA1537, Sodium azide (5 µg/plate) with strains TA 1535 and TA 100, 2-Nitrofluorene (10 µg/plate) with strains TA 1538 and TA 98; with S9 mix: 2-Aminoanthracene (1 µg/plate) with all tester strains
- Remarks:
- the above without S9-mix and 2-Aminoanthracene with S9-mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: not applicable
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: triplicates plates for the test material and negative control, two for positive controls
DETERMINATION OF CYTOTOXICITY
- Method: determination of toxicity by semiquantitative evaluation of the background lawn and the number of spontaneous revertant colonies
OTHER EXAMINATIONS:
Sterility test - Evaluation criteria:
- - at the end of the assay, a sterility check on S9 mix must show less than two viable colonies per 0.5 mL
- at the end of the test, a sterility check of the test material must show less than two viable colonies per plate
- the positive conrols must produce at least a threefold increase in the number of revertant colonies with regard to the mean value for the respective negative control
- the mean number of spontaneous revertant colonies in the negative controls must correspond to the following values:
strain TA 1535: 20 ± 15; strain TA 1537: 20 ± 15; strain TA 1538: 15 ± 10; strain TA 98: 40 ± 25; strain TA 100: 150 ± 90 - Statistics:
- no statistics performed
- Key result
- Species / strain:
- other: Salmonella typhimurium: strains TA 1535, TA 1537, TA 1538, TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- other: result could not be used for judgement because of failure of positive control
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- other: Salmonella typhimurium: strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- Positive controls validity:
- other: positive controls were judged to be valid, even when the increase of revertant colonies was less than 3-fold, but being 2-fold at least
- Additional information on results:
- - Preliminary test: The genetic characteristics of the bacterial strains were found to be unaltered.
- Test material toxicity: The test material did not induce toxic effects at a concentration of 10 mg/plate both in the absence and presence of the metabolic activation system.
- Negative control: The number of revertant colonies on the negative control plates fell within the normal range with the exception of strain TA 98 without metabolic activation.
- Positive control: The positive controls induced an at least threefold increase in the number of colonies with the exception of the positive controls with strain TA 100 with and without S9 mix and with strain TA 1535 with S9 mix. In these cases the increase of revertant colonies was not threefold: TA 100 without S9 mix 1.6, TA 100 with S9 mix: 1.8-fold; TA 1535 with S9 mix: 2.4-fold.
- Sterility test: The sterility test performed on the test material and on S9 mix did not show any bacterial contamination.
- Conclusions:
- Interpretation of results:
negative without metabolic activation
other: no evaluation of result possible for tester strain TA 100 because of failure of positive control
negative with metabolic activation valid for all strains tested
The test material did not induce an increase in the number of revertant colonies compared to the negative controls and was considered as non-mutagenic in this test-system. - Executive summary:
A test was performed to verify the mutagenic potentiol of the test material 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tris(C12-13-branched-alkyl) ester on Salmonella typhimurium according to Ames B.N., McCann J. and Yamasaki E. (1975).
The test was carried out on 5 strains of Salmonella typhimurium (TA 1535, TA 1537, TA1538, TA 98, TA 100). The mutagenic activity of the material was assessed by comparing the number of revertant colonies induced with the positive control. This activity was tested in the presence and absence of a metabolizing system and done directly in a petri dish. The test material was tested at concentrations of 100000, 10000, 1000, 100 and 10 µg/mL corresponding to doses of 10000, 1000, 100, 10 and 1 µg/petri dish. The results of the study can be summarized as follows: The test material at maximum concentration 10 mg/petri dish produced no increase in number of revertant colonies in comparison to the negative control. The result of the experiment with tester strain TA 100 without metabolic activation could not be evaluated because of a failure of the respective positive control. Nonetheless the test material 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tris(C12-13-branched-alkyl) ester was judged to be unable to induce mutations under these conditions at least in Salmonella typhimurium tester strains TA 1535, TA 1537, TA 1538 and TA 98.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Please see Analogue Approach
- Reason / purpose for cross-reference:
- read-across source
- Details on test system and experimental conditions:
DURATION
- Exposure duration:
Pre-experiment and Experiment I: 4 hours with and without S9 mix
Experiment II: 4 hours with S9 mix; 20 and 28 hours without S9 mix
- Fixation time (start of exposure up to fixation or harvest of cells):
Pre-experiment and Experiment I: 20 hours
Experiment II: 20 and 28 hours
SPINDLE INHIBITOR (cytogenetic assays): Colcemid, 0.2 µg/mL
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 200 well spread metaphases per concentration and control (100 per culture)
DETERMINATION OF CYTOTOXICITY
- Method:
Pre-experiment: The vitality of the cells was measured with the BCA reagent kit which contained the watersoluble and stable BCA (Bicinchonic acid) and an alkaline Cu2+ - solution (Pierce, USA). Cytotoxicity leaded to a reduction of the proliferation rate of the cells. This leaded to a reduction in the protein content of the cell culture as compared to the control cultures and was detected colourometrically (Absorbance at a wave length of 550 nm) after staining by BCA solution.
Experiments I and II: The mitotic index was determined by counting the number of cells in mitosis in 1000 cells to describe a cytotoxic effect. As an additional parameter for cytotoxic effects of the test item the relative cell density was calculated as the mean of twenty cell counts per test group ( cells within the visual field at a 400-fold magnification).
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: no- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- see details below
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Please see Analogue Justification
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- but of low order in the maximum practicable concentration
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
Referenceopen allclose all
Table #1: Salmonella typhimurium reverse mutation assay without metabolic activation | |||||
Concentration [µg/plate] |
Revertant colonies / plate mean ± SD |
||||
Strain TA 1535 | Strain TA 1537 | Strain TA 1538 | Strain TA 98 | Strain TA 100 | |
Negative control | 22 ± 5 | 14 ± 2 | 15 ± 3 | 17 ± 4 | 93 ± 12 |
1 | 25 ± 5 | 21 ± 1 | 13 ± 3 | 10 ± 0 | 95 ± 7 |
10 | 22 ± 6 | 14 ± 5 | 12 ± 1 | 16 ± 4 | 98 ± 17 |
100 | 22 ± 2 | 18 ± 7 | 11 ± 3 | 12 ± 3 | 98 ± 24 |
1000 | 18 ± 3 | 17 ± 6 | 11 ± 6 | 15 ± 7 | 116 ± 16 |
10000 | 19 ± 4 | 20 ± 4 | 9 ± 2 | 7 ± 2 | 121 ± 21 |
Positivecontrol | 433 ± 47 | 96 ± 3 | 264 ± 31 | 385 ± 18 | 152 ± 37 |
Table #2: Salmonella typhimurium reverse mutation assay with metabolic activation | |||||
Concentration [µg/plate] |
Revertant colonies / plate mean ± SD |
||||
Strain TA 1535 | Strain TA 1537 | Strain TA 1538 | Strain TA 98 | Strain TA 100 | |
Negative control | 27 ± 3 | 11 ± 5 | 18 ± 5 | 25 ± 4 | 189 ± 12 |
1 | 25 ± 5 | 21 ± 4 | 18 ± 2 | 26 ± 3 | 179 ± 23 |
10 | 21 ± 4 | 23 ± 3 | 18 ± 3 | 29 ± 2 | 213 ± 23 |
100 | 19 ± 3 | 20 ± 6 | 19 ± 4 | 27 ± 4 | 179 ± 6 |
1000 | 19 ± 4 | 20 ± 1 | 14 ± 4 | 26 ± 2 | 176 ± 24 |
10000 | 24 ± 4 | 20 ± 4 | 15 ± 1 | 25 ± 3 | 158 ± 19 |
Positivecontrol | 66 ± 3 | 480 ± 23 | 206 ± 14 | 216 ± 5 | 335 ± 21 |
SD = Standard Deviation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The test substance 1,2,3 -Propanetricarboxylic acid, 2 -hydroxy-, tris(C12 -13 -branched-alkyl) ester
did not cause mutagenic effects towards
bacteria in a standard Ames test. Also the source substance Tri (hexyl,
octyl, decyl) citrate and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-,
tri-C14-15-alkyl esters did not cause mutagenicity with and without
metabolic activation in Ames tests. The structurally related substance
source substance Tri-C18-22 (even numbered)-alkyl
2-hydroxypropane-1,2,3-tricarboxylate, is not mutagenic in mouse
lymphoma L5178Y cells, in either the absence or the presence of S9 mix,
when tested to the maximum practicable concentration of 1000 µg/mL. The
structurally related substance source substance Tri (hexyl, octyl,
decyl) citrate, did not induce structural chromosomal aberrations in the
V79 Chinese hamster cell line. Therefore it is concluded that the test
substance has no mutagenic properties.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
No classification for mutagenicity is indicated according to the classification, labeling and packaging (CLP) regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.